Aptevo Therapeutics (APVO) Other Gross PP&E Adjustments (2016 - 2025)
Aptevo Therapeutics' Other Gross PP&E Adjustments history spans 11 years, with the latest figure at -$5.0 million for Q3 2025.
- For Q3 2025, Other Gross PP&E Adjustments rose 10.03% year-over-year to -$5.0 million; the TTM value through Sep 2025 reached -$5.0 million, up 10.03%, while the annual FY2024 figure was $8.7 million, 3.11% up from the prior year.
- Other Gross PP&E Adjustments for Q3 2025 was -$5.0 million at Aptevo Therapeutics, down from -$4.8 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $12.1 million in Q4 2021 and bottomed at -$6.2 million in Q3 2022.
- The 5-year median for Other Gross PP&E Adjustments is -$4.8 million (2025), against an average of -$1.7 million.
- The largest annual shift saw Other Gross PP&E Adjustments surged 41.63% in 2022 before it plummeted 226.27% in 2023.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at $12.1 million in 2021, then tumbled by 31.42% to $8.3 million in 2022, then increased by 2.05% to $8.5 million in 2023, then increased by 3.11% to $8.7 million in 2024, then plummeted by 157.26% to -$5.0 million in 2025.
- Per Business Quant, the three most recent readings for APVO's Other Gross PP&E Adjustments are -$5.0 million (Q3 2025), -$4.8 million (Q2 2025), and -$4.6 million (Q1 2025).